Business
Salem, Massachusetts Will No Longer Arrest People for Psilocybin
Salem is now ending a witch hunt.
Salem, a city notorious for its 17th century witch trials, is creating a new reputation for itself by ceasing a modern-day witch hunt. As of this month, Salem is ending arrests for psilocybin mushrooms, Psychedelic Spotlight reports. It is now the sixth Massachusetts city to do so, after a 9-0 city council vote supporting the measure. Psilocybin is understood to be perhaps one of the safest drugs out there. Findings published in the Journal of Psychopharmacology shared that only 0.2% of magic mushroom users have sought emergency medical care after use. For those who had a lousy experience, it was a negative psychological (a bad trip) that resolved within 24 hours. In addition, you cannot die from a psilocybin physical overdose. (Comparatively, the World Health Organization reports that 3 million deaths yearly result from the destructive use of alcohol, representing 5.3% of all deaths.)
The passage of the Salem measure comes after the FDA has classified psilocybin as a “breakthrough therapy” for depression. Salem resident and neuroscientist Miyabe Shields said, “This is a win for science and the neurodivergent community to advance life-saving research on the complex innerworkings of our brains,” Psychedelic Spotlight reports.
As too many people know (according to Columbia University, one in ten Americans have depression), the standard treatment for depression, medicines like SSRIs and SNRIs, only improve symptoms in about 20 out of 100 people, data from the National Library of Medicine shows. Psychedelic options such as psilocybin and ketamine are literal lifesavers for the many folks who do not respond to traditional pharmaceuticals. Additionally, while medicines like SSRIs take several weeks to yield results, psychedelics can reduce depression in a matter of hours. Speaking about the measure, as Psychedelic Spotlight reports, disabled Marine Corp Veteran Michael Botelho, an active organizer with both Bay Staters and New England Veterans for Plant Medicine who served in combat during the Gulf War, shares that: “Through the VA system, I was prescribed over 160 medications, including opiates, to cope with PTSD before finding psilocybin mushrooms. For the first time in nearly 25 years, I have been able to sleep, overcome addiction to opiates, and work again.” Certainly, more New Englanders experiencing depression will feel comfortable using psychedelic treatments now that the risk of arrest is off the table.
Additionally, research shows that psilocybin has an influential role in the harm reduction movement. A study of 44,000 Americans in the U.S. Journal of Psychopharmacology discovered that psilocybin is associated with a 40% reduced risk of suffering opioid addiction. Data from the CDC shows that opioids were involved in 68,630 overdose deaths in 2020 (74.8% of all drug overdose deaths). This powerful property of psilocybin gained the Salem measure a surprising supporter. You don’t have to turn off N.W.A.’s “Fuck The Police,” but know that Lucas Miller, the Chief of Police for the City, endorsed the measure before the city’s final vote. “The indications that psilocybin could be helpful for opiate addiction is something that should not be ignored. We lose about 20 people in Salem a year to opioid overdose,” Miller says, Psychedelic Spotlight reports.
Salem may be the sixth Massachusetts city to end arrests for psilocybin mushrooms, but it won’t be the last.
The grassroots group who deserves credit for successfully implementing the campaign, which was years in the making, Bay Staters for Natural Medicine, has partnered with Somerville, Cambridge, Northampton, Easthampton, and Amherst to pass similar measures. In addition, the organization is currently pushing state legislation, which includes An Act Relative to Plant Medicine, which would legalize home growing and sharing of psilocybin and related plants.
Source: https://hightimes.com/news/salem-massachusetts-will-no-longer-arrest-people-for-psilocybin/
Business
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.
The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.
Golden Roots operates the The Cannabis Revolution Dispensary.
The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.
The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.
Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.
After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.
In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.
The company requested a hearing, which the regulator scheduled for Sept. 1.
At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.
Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.
Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.
The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:
- Regulators alleged in August that Albuquerque dispensary Sawmill Sweet Leaf sold out-of-state products and didn’t have a license for extraction.
- Paradise Exotics Distro lost its license in July after regulators alleged the company sold products made in California.
Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.
Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/
Business
Marijuana companies suing US attorney general in federal prohibition challenge
Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.
According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”
Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.
The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”
The companies want the case to go before the U.S. Supreme Court.
They hired prominent law firm Boies Schiller Flexner to represent them.
The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.
Similar challenges to the federal Controlled Substances Act (CSA) have failed.
One such challenge led to a landmark Supreme Court decision in 2005.
In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.
In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.
Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.
“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.
“Moreover, the facts on which those precedents are based are no longer true.”
Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”
While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.
“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”
Business
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.
The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).
Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.
Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.
That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.
Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.
Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.
A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.
Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/
-
Business1 year ago
Pot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business1 year ago
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business1 year ago
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business1 year ago
Washington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business1 year ago
Marijuana companies suing US attorney general in federal prohibition challenge
-
Business1 year ago
Legal Marijuana Handed A Nothing Burger From NY State
-
Business1 year ago
Can Cannabis Help Seasonal Depression
-
Blogs1 year ago
Cannabis Art Is Flourishing On Etsy